• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: 'Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'- Key Learning Points for Surgeons.

作者信息

Hurst K V, Lee R, Milosevic I, Handa A

机构信息

Nuffield Department of Surgical Sciences, Oxford, UK.

Nuffield Department of Surgical Sciences, Oxford, UK.

出版信息

Eur J Vasc Endovasc Surg. 2015 Jul;50(1):126-7. doi: 10.1016/j.ejvs.2015.02.022. Epub 2015 Apr 29.

DOI:10.1016/j.ejvs.2015.02.022
PMID:25933476
Abstract
摘要

相似文献

1
Re: 'Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'- Key Learning Points for Surgeons.回复：“新型口服抗凝剂达比加群、利伐沙班、阿哌沙班和依度沙班在静脉血栓栓塞症治疗及二级预防中的疗效与安全性：III期试验的系统评价和荟萃分析”——外科医生的关键学习要点
Eur J Vasc Endovasc Surg. 2015 Jul;50(1):126-7. doi: 10.1016/j.ejvs.2015.02.022. Epub 2015 Apr 29.
2
Re: 'Re. Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of VTE: A Systematic Review and Meta-analysis of Phase III Trials'.回复：“关于新型口服抗凝剂达比加群、利伐沙班、阿哌沙班和依度沙班在静脉血栓栓塞症治疗及二级预防中的疗效与安全性：III期试验的系统评价与荟萃分析”。
Eur J Vasc Endovasc Surg. 2015 Jul;50(1):127. doi: 10.1016/j.ejvs.2015.03.001. Epub 2015 Apr 13.
3
Re: 'Kakkos et al. Efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials'.回复：“卡卡科斯等人。新型口服抗凝剂达比加群、利伐沙班、阿哌沙班和依度沙班在静脉血栓栓塞症治疗和二级预防中的疗效与安全性：III期试验的系统评价和荟萃分析”。
Eur J Vasc Endovasc Surg. 2015 Mar;49(3):353. doi: 10.1016/j.ejvs.2014.11.019. Epub 2014 Dec 30.
4
Response to 'Re: Kakkos et al. Efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials'.对《回复：卡科斯等人。新型口服抗凝剂达比加群、利伐沙班、阿哌沙班和依度沙班在静脉血栓栓塞症治疗和二级预防中的疗效与安全性：III期试验的系统评价和荟萃分析》的回应
Eur J Vasc Endovasc Surg. 2015 Mar;49(3):353-4. doi: 10.1016/j.ejvs.2014.12.007. Epub 2014 Dec 30.
5
Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.编辑精选 - 新型口服抗凝药物达比加群、利伐沙班、阿哌沙班和依度沙班在治疗和静脉血栓栓塞症二级预防中的疗效和安全性：III 期临床试验的系统评价和荟萃分析。
Eur J Vasc Endovasc Surg. 2014 Nov;48(5):565-75. doi: 10.1016/j.ejvs.2014.05.001. Epub 2014 Jun 18.
6
New oral anticoagulants in the management of venous thromboembolism: a major advance?新型口服抗凝药在静脉血栓栓塞症治疗中的应用：一项重大进展？
Eur J Vasc Endovasc Surg. 2014 Nov;48(5):487-8. doi: 10.1016/j.ejvs.2014.07.007. Epub 2014 Aug 21.
7
New oral anticoagulants for the treatment of venous thromboembolism.新型口服抗凝药物治疗静脉血栓栓塞症。
Best Pract Res Clin Haematol. 2013 Jun;26(2):151-61. doi: 10.1016/j.beha.2013.07.005. Epub 2013 Jul 22.
8
Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.直接口服抗凝剂治疗急性静脉血栓栓塞症：系统评价和荟萃分析。
Thromb Res. 2014 Oct;134(4):774-82. doi: 10.1016/j.thromres.2014.06.020. Epub 2014 Jul 6.
9
Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients.静脉血栓栓塞症患者中，新型口服抗凝剂与标准治疗相比的医疗费用评估。
J Med Econ. 2014 Nov;17(11):763-70. doi: 10.3111/13696998.2014.950670. Epub 2014 Aug 12.
10
New oral anticoagulants for acute venous thromboembolism.用于急性静脉血栓栓塞症的新型口服抗凝剂。
Med Lett Drugs Ther. 2014 Jan 6;56(1433):3-4.